ENOVIS CORPORATION COMMON STOCK

Enovis Announces First Quarter 2025 Results

08 May 2025 03:00:00 By Nasdaq GlobeNewswire

Enovis to Host First Quarter 2025 Results Conference Call on May 8th

17 Apr 2025 04:00:00 By Nasdaq GlobeNewswire

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

02 Apr 2025 03:30:00 By Nasdaq GlobeNewswire

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

25 Mar 2025 05:00:01 By Nasdaq GlobeNewswire

Enovis to Participate in Upcoming Investor Conferences

05 Mar 2025 13:05:00 By Nasdaq GlobeNewswire

Enovis Announces Fourth Quarter and Full Year 2024 Results

26 Feb 2025 03:01:00 By Nasdaq GlobeNewswire

Enovis Announces Planned CEO Succession Process

26 Feb 2025 03:00:00 By Nasdaq GlobeNewswire

Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th

29 Jan 2025 04:00:01 By Nasdaq GlobeNewswire

Enovis™ Announces Leadership Change to International Surgical Business

17 Jan 2025 03:00:00 By Nasdaq GlobeNewswire

Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

06 Jan 2025 13:15:00 By Nasdaq GlobeNewswire

Enovis to Participate in Upcoming Investor Conferences

18 Nov 2024 13:10:00 By Nasdaq GlobeNewswire

Enovis Announces Third Quarter 2024 Results

06 Nov 2024 03:00:00 By Nasdaq GlobeNewswire

Enovis to Host Third Quarter 2024 Results Conference Call on November 6th

10 Oct 2024 04:00:00 By Nasdaq GlobeNewswire

Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

09 Sep 2024 12:50:00 By Nasdaq GlobeNewswire

Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting

05 Sep 2024 05:00:00 By Nasdaq GlobeNewswire

Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures

20 Aug 2024 05:00:00 By Nasdaq GlobeNewswire

Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability

19 Aug 2024 05:00:00 By Nasdaq GlobeNewswire

Enovis to Participate in Upcoming Investor Conferences

12 Aug 2024 13:10:00 By Nasdaq GlobeNewswire

Enovis Announces Second Quarter 2024 Results

07 Aug 2024 03:00:01 By Nasdaq GlobeNewswire

Enovis Announces Time Change for Second Quarter 2024 Results Conference Call

25 Jul 2024 03:00:00 By Nasdaq GlobeNewswire